Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac, Roman Chlíbek, Shinn‐Jang Hwang, Javier Díez‐Domingo, Olivier Godeaux, Myron J. Levin, Janet E. McElhaney, Joan Puig‐Barberà, Carline Vanden Abeele, Timo Vesikari, Daisuke Watanabe, Toufik Zahaf, Anitta Ahonen, Eugene Athan, José Fernando Barba‐Gómez, Laura Cámpora, Ferdinandus de Looze, H. Jackson Downey, Wayne Ghesquière, Iris Gorfinkel, Tiina Korhonen, Edward Leung, Shelly McNeil, Lidia Oostvogels, Lars Rombo, Jan Smetana, Lily Yin Weckx, W W Yeo, Thomas C. Heineman

New England Journal of Medicine, 2016

Westmead Institute for Medical Research, National Yang Ming Chiao Tung University, Illawarra Health and Medical Research Institute, University of Sydney, GlaxoSmithKline (Belgium), University of Defence, Taipei Veterans General Hospital, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, University of Colorado Anschutz Medical Campus, Health Sciences North, Tampere University, Tampere University, Aichi Medical University, Barwon Health, Deakin University, Secretaría de Salud de Jalisco, University of Queensland, Jacksonville Center for Clinical Research, United Christian Hospital, Nova Scotia Health Authority, Dalhousie University, Uppsala University, Stockholm County Council, Universidade Federal de São Paulo, University of Wollongong

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

1022

Citations

View on Google Scholar

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Abstract

Journal Details

Join JournalsHub

Welcome Back